JP2013515270A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013515270A5 JP2013515270A5 JP2012546198A JP2012546198A JP2013515270A5 JP 2013515270 A5 JP2013515270 A5 JP 2013515270A5 JP 2012546198 A JP2012546198 A JP 2012546198A JP 2012546198 A JP2012546198 A JP 2012546198A JP 2013515270 A5 JP2013515270 A5 JP 2013515270A5
- Authority
- JP
- Japan
- Prior art keywords
- sample
- acid
- cancer
- cancerous
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US28920609P | 2009-12-22 | 2009-12-22 | |
| US61/289,206 | 2009-12-22 | ||
| PCT/US2010/061811 WO2011087845A2 (en) | 2009-12-22 | 2010-12-22 | Metabolomic profiling of prostate cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013515270A JP2013515270A (ja) | 2013-05-02 |
| JP2013515270A5 true JP2013515270A5 (https=) | 2014-01-23 |
Family
ID=44151645
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012546198A Pending JP2013515270A (ja) | 2009-12-22 | 2010-12-22 | 前立腺癌の代謝学的プロファイリング |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US20110151497A1 (https=) |
| EP (1) | EP2517022A4 (https=) |
| JP (1) | JP2013515270A (https=) |
| CN (1) | CN102893157A (https=) |
| WO (1) | WO2011087845A2 (https=) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3326632B1 (en) * | 2012-02-23 | 2021-04-07 | Keio University | Combined anticancer drug sensitivity-determining marker |
| KR101462206B1 (ko) | 2013-06-26 | 2014-11-20 | 한국과학기술연구원 | 트립토판 대사 변화를 이용한 위암 진단용 기초 정보 제공 방법 |
| JP6222629B2 (ja) * | 2013-08-29 | 2017-11-01 | 花王株式会社 | 排尿障害のバイオマーカー |
| KR101955430B1 (ko) * | 2013-10-11 | 2019-03-11 | 주식회사 씨스퀘어 | 사르코신 대사산물 중 과산화물을 이용한 전립선암 진단 시험지, 그 제조 방법 및 이를 이용한 전립선암 진단에 필요한 정보를 제공하는 방법 |
| AU2015314220A1 (en) * | 2014-09-10 | 2017-04-20 | Biocrates Life Sciences Ag | Biomarkers for assessing breast cancer |
| WO2017210147A1 (en) * | 2016-05-29 | 2017-12-07 | Wei Jia | Liver disease-related biomarkers and methods of use thereof |
| JP6692422B2 (ja) * | 2016-06-10 | 2020-05-13 | 株式会社日立製作所 | 尿中代謝物による疾病診断法 |
| JP6280997B1 (ja) * | 2016-10-31 | 2018-02-14 | 株式会社Preferred Networks | 疾患の罹患判定装置、疾患の罹患判定方法、疾患の特徴抽出装置及び疾患の特徴抽出方法 |
| CN106770873B (zh) * | 2017-01-19 | 2019-02-19 | 中国人民解放军第四军医大学 | 一种膀胱癌诊断标志物及其应用和诊断试剂盒 |
| CN108344830B (zh) * | 2017-01-22 | 2020-10-16 | 中国科学院大连化学物理研究所 | 用于诊断前列腺癌的尿样组合标志物及检测试剂盒 |
| KR102077058B1 (ko) * | 2017-09-21 | 2020-02-13 | 연세대학교 산학협력단 | 대사체 프로파일링을 이용한 유방암의 예후 또는 위험도를 평가하는 방법 및 키트 |
| CN108414661B (zh) * | 2018-03-13 | 2020-04-21 | 中国医科大学 | 一种检测生物样品中氨含量的衍生化气相色谱-质谱方法 |
| EP3803390B1 (en) * | 2018-06-01 | 2024-05-01 | Lewis, Ian Andrew | Method for detecting urinary tract infections and sample analysis |
| IT201800007264A1 (it) * | 2018-07-17 | 2020-01-17 | Metodo per la diagnosi in vitro di carcinoma della prostata mediante biomarcatori urinari | |
| KR102405789B1 (ko) * | 2018-08-24 | 2022-06-07 | 고려대학교 세종산학협력단 | 키누레닌 경로 대사체를 포함하는 전립선암 진단용 바이오마커 조성물 |
| EP3629021A1 (en) * | 2018-09-26 | 2020-04-01 | Euroimmun Medizinische Labordiagnostika AG | Diagnosis of a neuroautoimmune disease |
| WO2021049862A1 (ko) * | 2019-09-10 | 2021-03-18 | 고려대학교 세종산학협력단 | 인돌아민 2,3-이산소화 효소를 포함하는 전립선암 진단용 마커 |
| WO2021213494A1 (en) * | 2020-04-23 | 2021-10-28 | YatHing Biotechnology Company Limited | Methods related to the diagnosis of prostate cancer |
| US20230384316A1 (en) * | 2020-10-20 | 2023-11-30 | Baylor College Of Medicine | Multiplex metabolic markers in plasma for early detection of african american prostate cancer |
| WO2022149487A1 (ja) * | 2021-01-07 | 2022-07-14 | 住友化学株式会社 | 前立腺がんの罹患の可能性を検査する方法 |
| CN114324674A (zh) * | 2022-01-21 | 2022-04-12 | 苏州南医大创新中心 | 一种精液中与无精子症有关的分子标志物及其检测方法和应用 |
| CN114487217B (zh) * | 2022-02-14 | 2024-06-25 | 广州市番禺区中心医院 | 一种区分前列腺癌和良性前列腺增生的标志物及试剂盒 |
| CN114544812B (zh) * | 2022-02-18 | 2023-06-30 | 复旦大学附属中山医院 | 一种代谢组合式标志物在诊断哮喘中的应用 |
| CN116465920B (zh) * | 2023-04-03 | 2023-11-10 | 汕头大学医学院 | 用于诊断食管癌的代谢标志物 |
| CN116106535B (zh) * | 2023-04-11 | 2023-08-11 | 南京品生医学检验实验室有限公司 | 生物标志物组合在制备乳腺癌预测产品中的应用 |
| US20250076301A1 (en) * | 2023-09-05 | 2025-03-06 | National Taiwan University | Biomarker for prostate cancer |
| DE102023125870A1 (de) * | 2023-09-25 | 2025-03-27 | Numares Ag | Verwendung eines Markersets für die Diagnostik des Prostatakarzinoms |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6020139A (en) * | 1995-04-25 | 2000-02-01 | Oridigm Corporation | S-adenosyl methionine regulation of metabolic pathways and its use in diagnosis and therapy |
| US6866837B2 (en) * | 1998-06-05 | 2005-03-15 | Mallinckrodt Inc. | Radiolabeled peptides for the diagnosis and treatment of breast and prostate tumors and metastases of such tumors |
| US7329489B2 (en) * | 2000-04-14 | 2008-02-12 | Matabolon, Inc. | Methods for drug discovery, disease treatment, and diagnosis using metabolomics |
| US20020009740A1 (en) * | 2000-04-14 | 2002-01-24 | Rima Kaddurah-Daouk | Methods for drug discovery, disease treatment, and diagnosis using metabolomics |
| WO2004063355A2 (en) * | 2003-01-10 | 2004-07-29 | Protein Design Labs, Inc. | Novel methods of diagnosis of metastatic cancer, compositions and methods of screening for modulators of matastatic cancer |
| EP1677740A2 (en) * | 2003-10-16 | 2006-07-12 | The Administrators Of The Tulane Educational Fund | Methods and compositions for treating cancer |
| US20070055456A1 (en) * | 2005-08-31 | 2007-03-08 | Daniel Raftery | NMR method for differentiating complex mixtures |
| WO2007066216A2 (en) * | 2005-12-09 | 2007-06-14 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Fatty acids profile correlated to the propensity or risk of breast cancer |
| CN101454331A (zh) * | 2006-03-24 | 2009-06-10 | 菲诺梅诺米发现公司 | 有效用于诊断前列腺癌的生物标记，及其方法 |
| US20090075284A1 (en) * | 2006-09-19 | 2009-03-19 | The Regents Of The University Of Michigan | Metabolomic profiling of prostate cancer |
| EP2657705A3 (en) * | 2006-09-19 | 2013-12-25 | Metabolon Inc. | Biomarkers for prostate cancer and methods using the same |
| EP2597464B1 (en) * | 2007-08-16 | 2015-02-25 | The Regents of the University of Michigan | Metabolomic profiling of prostate cancer |
-
2010
- 2010-12-22 JP JP2012546198A patent/JP2013515270A/ja active Pending
- 2010-12-22 US US12/976,177 patent/US20110151497A1/en not_active Abandoned
- 2010-12-22 WO PCT/US2010/061811 patent/WO2011087845A2/en not_active Ceased
- 2010-12-22 CN CN2010800645336A patent/CN102893157A/zh active Pending
- 2010-12-22 EP EP10843575.1A patent/EP2517022A4/en not_active Withdrawn
-
2013
- 2013-03-12 US US13/796,988 patent/US20130261022A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013515270A5 (https=) | ||
| Li et al. | Ultrasensitive and reversible nanoplatform of urinary exosomes for prostate cancer diagnosis | |
| Sha et al. | Programmable DNA-fueled electrochemical analysis of lung cancer exosomes | |
| Wang et al. | Simultaneous isolation and detection of circulating tumor cells with a microfluidic silicon-nanowire-array integrated with magnetic upconversion nanoprobes | |
| Yin et al. | A multifunctional platform for the capture, release, and enumeration of circulating tumor cells based on aptamer binding, nicking endonuclease-assisted amplification, and inductively coupled plasma mass spectrometry detection | |
| EP3206034A3 (en) | Use of fatty acids in methods for detecting cancer | |
| BR112012032537B8 (pt) | Métodos para diagnosticar se um indivíduo tem ou não câncer de pulmão de não pequenas células, ou para fornecer informações sobre câncer de pulmão de não pequenas células em um indivíduo | |
| EP3988668A3 (en) | Kit or device for detecting early stage pancreatic cancer or pancreatic cancer precursor lesions and detection method therefor | |
| JP2009538607A5 (https=) | ||
| JP2014144959A5 (https=) | ||
| CA2815892C (en) | Analytical methods and arrays for use in the same | |
| WO2015070037A3 (en) | Polynucleotide conjugates and methods for analyte detection | |
| EP3029153A3 (en) | Mesothelioma biomarkers and uses thereof | |
| BR112013009008A2 (pt) | métodos e kits para a detecção de células circulantes de tumor em pacientes pancreáticos com o uso de reagentes de detecção de captura e de coquetel poliespecíficos | |
| EP4491741A3 (en) | Compositions and methods for analyte detection | |
| CN106066324B (zh) | 一种电致化学发光生物传感器标记物的制备方法 | |
| MX2014004860A (es) | Biomarcadores de cancer de pulmon y usos de los mismos. | |
| Leung et al. | Ovarian cancer biomarkers: current state and future implications from high-throughput technologies | |
| EP3159695A3 (en) | Methods for diagnosing pancreatic cancer | |
| WO2012103337A3 (en) | Assays and methods to sequence microbes directly from immune complexes | |
| CN103424402A (zh) | 一种体液巯基检测试剂盒 | |
| WO2017155926A8 (en) | Prostatic liquid biopsy for the detection of prostate cancer and benign prostatic hyperplasia | |
| Pallante et al. | Circulating tumour cells in predictive molecular pathology: focus on drug-sensitive assays and 3D culture | |
| CN203815490U (zh) | 超声波探头标记笔架 | |
| JP2013513812A5 (https=) |